VIDHIING
Vidhi Specialty Food Ingredients Limited
Synthetic food, drug and cosmetic colours manufacturer
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
vidhifoodcolors.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Vidhi (Vidhi Specialty Food Ingredients) makes synthetic food, drug and cosmetic colours (dyes, lakes and blends) and sells them to food, pharmaceutical and personal-care customers in more than 80 countries.
Company snapshot
39thBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓Debt-to-equity of 0.18x — the company is largely funded by its own money, not borrowed funds.
- ✗Only 50% of operating profit came in as cash over the last three years — much of it is tied up in unpaid bills or stock.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 80 Cr | 63 Cr | 81 Cr | 83 Cr | 91 Cr | 99 Cr | 110 Cr | 88 Cr | 75 Cr | 94 Cr | 123 Cr | 146 Cr |
| Operating expenses (approx.) | 66 Cr | 49 Cr | 65 Cr | 69 Cr | 76 Cr | 80 Cr | 90 Cr | 67 Cr | 57 Cr | 75 Cr | 102 Cr | 120 Cr |
| EBITDA | 14 Cr | 14 Cr | 16 Cr | 14 Cr | 15 Cr | 19 Cr | 20 Cr | 21 Cr | 18 Cr | 19 Cr | 21 Cr | 26 Cr |
| OPM % | 17.1% | 22.8% | 19.8% | 17.0% | 16.6% | 19.2% | 18.2% | 23.4% | 23.6% | 20.3% | 16.8% | 17.8% |
| Other income | 0.24 Cr | 0.04 Cr | 0.29 Cr | 0.15 Cr | 0.78 Cr | 0.10 Cr | 0.56 Cr | 0.49 Cr | 0.68 Cr | 0.23 Cr | 0.38 Cr | 0.20 Cr |
| Interest | 0.88 Cr | 0.77 Cr | 0.41 Cr | 0.44 Cr | 0.42 Cr | 0.55 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr |
| Depreciation | 1 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr |
| Profit before tax | 12 Cr | 12 Cr | 14 Cr | 12 Cr | 14 Cr | 17 Cr | 18 Cr | 17 Cr | 15 Cr | 16 Cr | 18 Cr | 23 Cr |
| Tax % | 22.4% | 26.6% | 24.8% | 28.8% | 23.8% | 25.1% | 32.4% | 25.9% | 29.0% | 21.6% | 26.2% | 25.6% |
| Net profit | 9 Cr | 9 Cr | 10 Cr | 8 Cr | 10 Cr | 13 Cr | 12 Cr | 13 Cr | 11 Cr | 12 Cr | 13 Cr | 17 Cr |
| EPS (₹) | ₹1.81 | ₹1.73 | ₹2.09 | ₹1.69 | ₹1.81 | ₹2.55 | ₹2.37 | ₹2.54 | ₹2.11 | ₹2.49 | ₹2.63 | ₹3.43 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 225 Cr | 266 Cr | 537 Cr | 404 Cr | 303 Cr | 382 Cr | 380 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 174 Cr | 214 Cr | 452 Cr | 348 Cr | 246 Cr | 314 Cr | 302 Cr | Sign in free for the trailing twelve months |
| EBITDA | 50 Cr | 52 Cr | 85 Cr | 56 Cr | 57 Cr | 68 Cr | 78 Cr | Sign in free for the trailing twelve months |
| OPM % | 22.5% | 19.7% | 15.8% | 13.8% | 18.8% | 17.9% | 20.5% | Sign in free for the trailing twelve months |
| Other income | 0.64 Cr | 2 Cr | 1 Cr | 1 Cr | 1 Cr | 2 Cr | 2 Cr | Sign in free for the trailing twelve months |
| Interest | 3 Cr | 2 Cr | 4 Cr | 4 Cr | 3 Cr | 2 Cr | 5 Cr | Sign in free for the trailing twelve months |
| Depreciation | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 6 Cr | 8 Cr | 9 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 45 Cr | 50 Cr | 79 Cr | 50 Cr | 49 Cr | 60 Cr | 66 Cr | Sign in free for the trailing twelve months |
| Tax % | 24.9% | 26.2% | 25.8% | 24.3% | 25.3% | 27.7% | 25.6% | Sign in free for the trailing twelve months |
| Net profit | 34 Cr | 37 Cr | 59 Cr | 38 Cr | 36 Cr | 43 Cr | 49 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹6.76 | ₹7.33 | ₹11.75 | ₹7.55 | ₹7.31 | ₹8.68 | ₹9.80 | Sign in free for the trailing twelve months |
| Dividend payout % | — | 11.0% | 5.1% | 10.5% | 19.1% | 51.8% | 46.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr |
| Reserves | 124 Cr | 156 Cr | 212 Cr | 246 Cr | 275 Cr | 296 Cr | 323 Cr |
| Borrowings | 32 Cr | 30 Cr | 90 Cr | 50 Cr | 20 Cr | 66 Cr | 58 Cr |
| Other liabilities | 26 Cr | 34 Cr | 45 Cr | 31 Cr | 25 Cr | 29 Cr | 33 Cr |
| Total liabilities | 187 Cr | 226 Cr | 352 Cr | 331 Cr | 325 Cr | 396 Cr | 419 Cr |
| Fixed assets (net) | 40 Cr | 27 Cr | 36 Cr | 44 Cr | 121 Cr | 126 Cr | 133 Cr |
| CWIP | 6 Cr | 8 Cr | 37 Cr | 68 Cr | 4 Cr | 4 Cr | 4 Cr |
| Investments | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Loans & advances | 0.37 Cr | 0.81 Cr | 0.88 Cr | 0.92 Cr | 1 Cr | 1 Cr | 1 Cr |
| Inventories | 34 Cr | 40 Cr | 73 Cr | 61 Cr | 56 Cr | 75 Cr | 81 Cr |
| Trade receivables | 77 Cr | 95 Cr | 150 Cr | 101 Cr | 88 Cr | 129 Cr | 143 Cr |
| Cash & bank | 7 Cr | 4 Cr | 1 Cr | 7 Cr | 12 Cr | 20 Cr | 12 Cr |
| Other assets | 23 Cr | 51 Cr | 54 Cr | 49 Cr | 42 Cr | 42 Cr | 45 Cr |
| Total assets | 187 Cr | 226 Cr | 352 Cr | 331 Cr | 325 Cr | 396 Cr | 419 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 33 Cr | 11 Cr | -21 Cr | 96 Cr | 63 Cr | -5 Cr | 42 Cr |
| Cash from investing | -12 Cr | -3 Cr | -40 Cr | -42 Cr | -19 Cr | -7 Cr | -15 Cr |
| Cash from financing | -24 Cr | -8 Cr | 53 Cr | -47 Cr | -40 Cr | 19 Cr | -35 Cr |
| Net cash flow | -4 Cr | 0.47 Cr | -9 Cr | 6 Cr | 4 Cr | 8 Cr | -8 Cr |
| Free cash flow (OCF − Capex) | 28 Cr | 8 Cr | -62 Cr | 53 Cr | 44 Cr | -12 Cr | 26 Cr |
Ratios
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | 29.9% | 26.7% | 27.0% | 17.8% | 17.3% | 17.0% | 18.3% |
| ROE % | 26.4% | 22.7% | 27.0% | 15.0% | 13.0% | 14.4% | 14.9% |
| Debtor days | 125 | 129 | 102 | 91 | 106 | 122 | 137 |
| Inventory days | 117 | 143 | 180 | 136 | 121 | 127 | 158 |
| Days payable | 62 | 98 | 91 | 51 | 34 | 32 | 41 |
| Cash conversion cycle | 181 | 174 | 191 | 175 | 193 | 217 | 254 |
| OCF / EBITDA % | 65.1% | 21.3% | -25.4% | 172.1% | 111.3% | -6.7% | 54.4% |
| OCF / EBITDA % (3 years) | — | — | 12.0% | 44.4% | 69.9% | 85.4% | 49.8% |
| Debt / equity | 0.25 | 0.19 | 0.41 | 0.20 | 0.07 | 0.22 | 0.18 |
| Current ratio | 2.59 | 2.99 | 2.32 | 2.86 | 4.79 | 2.92 | 3.30 |
| Net debt / EBITDA | 0.50 | 0.50 | 1.05 | 0.76 | 0.14 | 0.67 | 0.59 |